English | Spanish
ecancer
Supporting oncology professionals through education
Login Register

The content on this site is intended for healthcare professionals only

  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

News

  • Latest news
  • Sign up for news alerts
  • Submit your news

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Journal information

  • Journal home
  • Charges
  • Editorial board
  • Founding editors
  • Editor-in-chief
  • Contact us

Author information

  • Submit article
  • Author guidelines
  • Editorial policies
  • Copyright information
  • Why publish with us

Reviewer information

  • Reviewer guidelines

Memberships

Open Access Scholarly Publishers Association Crossref Healthcare Information For All Commitee On Publication Ethics

Videos

  • Recent videos
  • Sign up

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Conferences

  • Latest conferences
  • Sign up for latest coverage
  • Submit your event

About ecancer

  • About ecancer
  • Our founders
  • Funding statement
  • Contact us
  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology
+ -
Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

ecancer and the City Cancer Challenge have formed an educational collaboration. Learners who are part of the City Cancer Challenge's project can access additional education provided by them.

Please login or register. Then you can use this button to confirm you are part of this project.
Register for free Already have an account? Login
Videos [1996]
News [3249]
Articles [135]
Editorials [3]
Conferences [122]
elearning [18]
FDA approves avapritinib for advanced systemic mastocytosis
FDA approves avapritinib for advanced systemic mastocytosis
EHA 2021: First-line ibrutinib + venetoclax is superior to chlorambucil + obinutuzumab for chronic lymphocytic leukaemia/small lymphocyte lymphoma
EHA 2021: First-line ibrutinib + venetoclax is superior to chlorambucil + obinutuzumab for chronic lymphocytic...
EHA 2021: Daratumumab maintenance improves progression-free survival after autologous stem cell transplantation in multiple myeloma patients
EHA 2021: Daratumumab maintenance improves progression-free survival after autologous stem cell transplantation in...
EHA 2021: Overall survival benefit established with daratumumab plus lenalidomide and dexamethasone in elderly patients with transplant-ineligible newly diagnosed multiple myeloma
EHA 2021: Overall survival benefit established with daratumumab plus lenalidomide and dexamethasone in elderly...
EHA 2021: ALPINE study reveals superior safety and efficacy of zanubrutinib compared with ibrutinib
EHA 2021: ALPINE study reveals superior safety and efficacy of zanubrutinib compared with ibrutinib
EHA 2021: Clinical trial efficacy of CAR-T therapy in patients with diffuse large B-cell lymphoma Is mirrored in the real world
EHA 2021: Clinical trial efficacy of CAR-T therapy in patients with diffuse large B-cell lymphoma Is mirrored in...
EHA 2021: Combination targeted therapy provides durable remission for patients with CLL
EHA 2021: Combination targeted therapy provides durable remission for patients with CLL
Ludwig cancer research study shows how novel drug screen can individualise cancer therapy
Ludwig cancer research study shows how novel drug screen can individualise cancer therapy
New drug combo found effective against high-risk leukaemia
New drug combo found effective against high-risk leukaemia
Study identifies risk for some childhood cancer patients developing secondary leukaemia
Study identifies risk for some childhood cancer patients developing secondary leukaemia
<1...7172737475...325>

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation

  • Contact
  • Projects
  • Cookie Policy
  • Terms of Use
  • Desktop Site
  • Privacy Policy
© 2025 ecancer, all rights reserved
UK registered charity number: 1176307
Back to Top